A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
11/1998
11/19/1998	WO1998051330A1 Method and compositions for treating hyperlipidemia and other conditions
11/19/1998	WO1998051324A1 Peptide parathyroid hormone analogs
11/19/1998	WO1998051305A1 Use of 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)-ethoxy)benzyl)2,4-thiazolidinedione in the treatment of polycystic ovary syndrome and gestational diabetes
11/19/1998	WO1998051277A1 Medical uses of pyruvates
11/19/1998	CA2290443A1 Peptide parathyroid hormone analogs
11/19/1998	CA2289704A1 Medical uses of pyruvates
11/19/1998	CA2289573A1 N-triazolyl-2-indolecarboxamides and their use as cck-a agonists
11/19/1998	CA2288710A1 3-epi vitamin d2 compounds and uses thereof
11/19/1998	CA2287839A1 Therapeutic and diagnostic tools for impaired glucose tolerance conditions
11/19/1998	CA2282473A1 Use of 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)-ethoxy)benzyl)2,4-thiazolidinedione in the treatment of polycystic ovary syndrome and gestational diabetes
11/19/1998	CA2221866A1 A novel member of the il-1 family, il-1 delta
11/18/1998	EP0878542A2 cDNA clone HMTMF81 that encodes a novel human 7-transmembrane receptor
11/18/1998	EP0878479A2 G-protein coupled receptor (HOFNH30)
11/18/1998	EP0877803A1 Ob protein receptor and related compositions and methods
11/18/1998	EP0877760A1 Mhc complexes and uses thereof
11/18/1998	EP0877759A1 Methods for increasing endogenous levels of corticotropin-releasing factor
11/18/1998	EP0877750A1 Sugar-substituted 2-azetidinones useful as hypocholesterolemic a gents
11/18/1998	EP0877748A1 Pyrido-1,2,4-thiadiazine and pyrido-1,4-thiazine derivatives, their preparation and use
11/18/1998	EP0877743A1 ((3"-thioxacyclohex-1"-enyl))-but-3'-ene-1'-ynyl)aryl and heteroaryl carboxylic acids and esters having retinoid-like biological activity
11/18/1998	EP0877627A1 Obesity protein analog compounds and formulations thereof
11/18/1998	EP0877563A1 Food and vitamin preparations containing the natural isomer of reduced folates
11/18/1998	EP0877555A1 Method of inhibiting immune system destruction of transplanted viable cells
11/18/1998	EP0757669B1 O-acyl-4-phenyl-cyclohexanols, their salts, medicaments containing such compounds and their use, as well as a method of preparing them
11/18/1998	EP0697821B1 Cholesterol lowering drink mix compositions
11/18/1998	CN1199400A 8-azabicycle [3.2.1]oct-2-ene derivs, their preparation and use
11/18/1998	CN1199340A Analogs of parathyroid hormone
11/17/1998	US5837733 Method for reducing secetion of apolipoprotein B in animals by administering conjugated linoleic acid
11/17/1998	US5837727 Method for altering blood lipid levels
11/17/1998	US5837498 Corpuscles of stannius protein, stanniocalcin
11/13/1998	CA2230971A1 G-protein coupled receptor (hofnh30)
11/12/1998	WO1998050572A1 HMG-CoA REDUCTASE INHIBITOR PREPARATION PROCESS
11/12/1998	WO1998050542A1 Uncoupling protein homologue: ucp 3
11/12/1998	WO1998050356A1 2-indolinone derivatives as modulators of protein kinase activity
11/12/1998	WO1998050344A1 Substituted 3,3-diamino-2-propenenitriles, their preparation and use
11/12/1998	WO1998050054A1 Plant extracts for the treatment of increase bone resorption
11/12/1998	WO1998050028A1 Mtp inhibitors and fat soluble vitamin therapeutic combinations to lower serum lipid levels
11/12/1998	WO1998031707A3 Transgenic animals with disrupted npy y1 receptor genes
11/12/1998	CA2289102A1 2-indolinone derivatives as modulators of protein kinase activity
11/12/1998	CA2289099A1 Substituted 3,3-diamino-2-propenenitriles, their preparation and use
11/12/1998	CA2289001A1 Novel heterocyclic compounds
11/12/1998	CA2288901A1 Uncoupling protein homologue: ucp 3
11/12/1998	CA2286341A1 Mtp inhibitors and fat soluble vitamin therapeutic combinations to lower serum lipid levels
11/11/1998	EP0877089A1 HMG-CoA reductase inhibitor preparation process
11/11/1998	EP0877083A1 A novel human G-protein coupled receptor (HCEPT09)
11/11/1998	EP0876395A1 INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME
11/11/1998	EP0876379A1 Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use
11/11/1998	EP0876372A1 Heteroarylcarboxamide derivatives
11/11/1998	EP0876359A1 (-) cis-6(s)-phenyl-5(r) 4-(2-pyrrolidin-1-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol d-tartrate
11/11/1998	EP0876151A1 Microencapsulated genetically engineered microorganisms for clinical application
11/11/1998	EP0876110A1 Enteral formula or nutritional supplement containing arachidonic and docosahexaenoic acids
11/11/1998	EP0759919B1 Azolidinediones as antihyperglycemic agents
11/11/1998	CN1198668A Naphthyl and dihydronaphthyl intermediates, compounds, compositions, and methods
11/11/1998	CN1040646C Enatiomeric hydroxylated xanthine compound
11/10/1998	US5834587 G-protein coupled receptor, HLTEX 11
11/10/1998	US5834508 Ketone derivatives
11/10/1998	US5834504 Modulating, inhibiting abnormal cell proliferation; enzyme inhibition
11/10/1998	US5834501 Heterocyclic compounds having anti-diabetic activity and their use
11/10/1998	US5834469 Endothelin receptor antagonists
11/10/1998	US5834432 Use of angiotensin II Type 2 receptor agonists in tissue repair
11/10/1998	US5834192 Amino acid sequences, nucleotide sequenes and complements; identified from breast tumor libraries; diagnosing with hybridization complexes; host cells transfected with expression vectors; antisense molecules for treatment
11/10/1998	US5834032 Compositions and methods for treating diabetes
11/10/1998	US5833987 Treatment of T cell mediated autoimmune disorders
11/07/1998	CA2231754A1 A novel human g-protein coupled receptor hcept09
11/05/1998	WO1998049350A1 In vivo use of recombinagenic oligonucleobases to correct genetic lesions in hepatocytes
11/05/1998	WO1998049333A2 Eukaryotic gene expression cassette and uses thereof
11/05/1998	WO1998049326A1 Method for cleavage of fusion proteins
11/05/1998	WO1998049319A1 Human lysophospholipase
11/05/1998	WO1998049129A1 Conjugated linolenic acid-based synthetic triglycerides
11/05/1998	WO1998048810A1 Composition and methods using an eutomer
11/05/1998	WO1998048806A1 Indene compounds having activity as serms
11/05/1998	WO1998048785A2 Allelic polygene diagnosis of reward deficiency syndrome and treatment
11/05/1998	WO1998037094A3 Secreted proteins and polynucleotides encoding them
11/05/1998	CA2288990A1 Allelic polygene diagnosis of reward deficiency syndrome and treatment
11/05/1998	CA2288209A1 In vivo use of recombinagenic oligonucleobases to correct genetic lesions in hepatocytes
11/05/1998	CA2288073A1 Human lysophospholipase
11/05/1998	CA2287244A1 Indene compounds having activity as serms
11/05/1998	CA2286861A1 Method for cleavage of fusion proteins
11/04/1998	EP0875573A2 CRFG-1b, a target and marker for chronic renal failure
11/04/1998	EP0875572A2 CRFG-1a, a target and marker for chronic renal failure
11/04/1998	EP0875566A2 Novel G-protein coupled receptor (HFGAN72X)
11/04/1998	EP0875253A2 Chondroitinase compositions
11/04/1998	EP0874850A1 Novel tricyclic compounds for the inhibition of the ice/ced-3 protease family of enzymes
11/04/1998	EP0874812A1 Novel 2,3,5-trimethyl-4-hydroxy anilide derivatives, preparation thereof and therapeutical use thereof
11/04/1998	EP0874639A1 Peptide inhibitors of a phosphotyrosine-binding domain containing protein
11/04/1998	EP0874626A1 Use of inhibitors of retinoic acid activity for wound healing
11/04/1998	EP0874621A1 Pharmaceutical compositions
11/04/1998	EP0619802B1 A mixture of higher primary aliphatic alcohols and its pharmaceutical uses
11/04/1998	CN1197797A New heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
11/03/1998	USRE35948 Pharmaceutical compositions
11/03/1998	US5831115 Inhibitors of squalene synthase and protein farnesyltransferase
11/03/1998	US5831017 Divalent metal complex
11/03/1998	US5830914 Apoptosis-controlling agent
11/03/1998	US5830909 Dietetics
11/03/1998	US5830887 Cancer, pms, menopause and hypercholesterolemia
11/03/1998	US5830671 Method for assaying for modulators of cytokines of the TFG β superfamily
11/03/1998	US5830492 Matrix containing a hormone encapsulated with polymer
11/03/1998	US5830454 Mouse models of human disease
10/1998
10/30/1998	CA2236248A1 Crfg-1a, a target and marker for chronic renal failure
10/30/1998	CA2231748A1 Novel g-protein coupled receptor (hfgan72x)
10/30/1998	CA2228736A1 Crfg-1b, a target and marker for chronic renal failure

1 ... 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 ... 1298